NCT02214563View on ClinicalTrials.gov

Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

December 31, 2016

Conditions
Kidney Failure, ChronicAnemiaVitamin D DeficiencyBone Diseases, Metabolic
Interventions
DIETARY_SUPPLEMENT

Cholecalciferol

Made for this trial by Molecular Physiological Chemistry Laboratory, Inc.

DIETARY_SUPPLEMENT

Olive oil

Trial Locations (7)

662-0918

Hyogo Prefectural Nishinomiya Hospital, Nishinomiya

573-0075

Higashikouri hospital, Hirakata

565-0871

Department of Comprehensive Kidney Disease Research, Osaka University Graduate School of Medicine, Suita

861-4112

Akebono clinic, Kumamoto

543-0052

Obi clinic, Osaka

552-0007

Nishi clinic, Osaka

559-0013

Futaba clinic, Osaka

Sponsors

Collaborators (1)

Obi clinic
All Listed Sponsors
collaborator

The Japan Kidney Foundation

OTHER

collaborator

Molecular Physiological Chemistry Laboratory, Inc.

OTHER

collaborator

Obi clinic

UNKNOWN

collaborator

Higashikouri Hospital

UNKNOWN

collaborator

Nishi clinic

UNKNOWN

collaborator

Futaba clinic

UNKNOWN

collaborator

Akebono clinic

UNKNOWN

lead

Takayuki Hamano

OTHER

NCT02214563 - Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis Patients | Biotech Hunter | Biotech Hunter